Takeda Pharmaceutical Company
E474950
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
All labels observed (3)
| Label | Occurrences |
|---|---|
| Takeda Pharmaceutical Company canonical | 5 |
| Takeda Oncology | 1 |
| Takeda Pharmaceutical Company Limited | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4850505 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Takeda Pharmaceutical Company Context triple: [Heptares Therapeutics, collaboratesWith, Takeda Pharmaceutical Company]
-
A.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
B.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
C.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
-
D.
Sankyo Company
Sankyo Company is a Japanese pharmaceutical firm known for its role in developing cholesterol-lowering statin drugs and later becoming part of Daiichi Sankyo.
-
E.
Sumitomo Corporation
Sumitomo Corporation is a major Japanese multinational trading and investment company and one of the core members of the Sumitomo Group conglomerate.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Takeda Pharmaceutical Company Target entity description: Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
A.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
B.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
C.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
-
D.
Sankyo Company
Sankyo Company is a Japanese pharmaceutical firm known for its role in developing cholesterol-lowering statin drugs and later becoming part of Daiichi Sankyo.
-
E.
Sumitomo Corporation
Sumitomo Corporation is a major Japanese multinational trading and investment company and one of the core members of the Sumitomo Group conglomerate.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
multinational corporation ⓘ public company ⓘ |
| acquired | Shire plc ⓘ |
| acquisitionOfShireCompletedIn | 2019 ⓘ |
| coreTherapeuticArea |
gastroenterology
ⓘ
neuroscience ⓘ oncology ⓘ rare diseases ⓘ |
| corporateSlogan | Better Health, Brighter Future ⓘ |
| country | Japan ⓘ |
| engagesIn |
global commercialization of medicines
ⓘ
manufacturing of pharmaceuticals ⓘ research and development of innovative medicines ⓘ |
| focusesOn |
gastroenterology
ⓘ
neuroscience ⓘ oncology ⓘ plasma-derived therapies ⓘ rare diseases ⓘ vaccines ⓘ |
| follows | Takeda-ism values ⓘ |
| foundedIn | 1781 ⓘ |
| founder | Chobei Takeda I ⓘ |
| hasNotableProductArea |
cancer treatments
ⓘ
central nervous system disorder treatments ⓘ gastrointestinal disease treatments ⓘ rare genetic disease treatments ⓘ |
| hasRAndDCentersIn |
Europe
ⓘ
Japan ⓘ United States ⓘ
linked to:
United States of America
|
| hasSubsidiary | Shire plc ⓘ |
| headquartersLocation |
Japan
ⓘ
Tokyo ⓘ |
| industry |
biotechnology industry
ⓘ
pharmaceutical industry ⓘ |
| legalForm | Kabushiki gaisha ⓘ |
| listedOn |
New York Stock Exchange
ⓘ
Tokyo Stock Exchange ⓘ |
| numberOfEmployees | over 50,000 ⓘ |
| operatesIn | more than 80 countries ⓘ |
| revenueRanking |
one of the largest pharmaceutical companies in Asia
ⓘ
one of the largest pharmaceutical companies in the world ⓘ |
| TakedaIsmValuesInclude |
Fairness
ⓘ
Honesty ⓘ Integrity ⓘ Perseverance ⓘ |
| tradedAs |
NYSE:TAK
ⓘ
TSE:4502 ⓘ
linked to:
TSE
|
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Takeda Pharmaceutical Company Description of subject: Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
Referenced by (7)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: Takeda Pharmaceutical Company
linked to: Takeda Pharmaceutical Company